Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells

This publication has 18 references indexed in Scilit:

• Ribonuclease inhibitor as an intracellular sentry
  Nucleic Acids Research, 2003
• Genetic screen to dissect protein–protein interactions: ribonuclease inhibitor–ribonuclease A as a model system
  Methods, 2002
• Antiangiogenesis: Current Clinical Data and Future Perspectives
  Oncology Research and Treatment, 2002
• Tumor angiogenesis as a therapeutic target
  Drug Discovery Today, 2001
• Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin
  Cancer Gene Therapy, 2001
• Molecular recognition of human angiogenin by placental ribonuclease inhibitor_an X-ray crystallographic study at 2.0Aresolution
  The EMBO Journal, 1997
• cAMP-Mediated Signals as Determinants for Apoptosis in Primary Granulosa Cells
  Experimental Cell Research, 1995
• Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats
  Nature, 1993
• Chemosensitivity testing of small cell lung cancer using the MTT assay
  British Journal of Cancer, 1991
• Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor
  Biochemistry, 1989